Replimune Group Inc (REPL)
10.80
-0.60
(-5.26%)
USD |
NASDAQ |
Nov 15, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Total Assets (Quarterly): 498.20M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 498.20M |
| June 30, 2024 | 534.96M |
| March 31, 2024 | 487.72M |
| December 31, 2023 | 532.93M |
| September 30, 2023 | 562.40M |
| June 30, 2023 | 603.89M |
| March 31, 2023 | 646.59M |
| December 31, 2022 | 678.55M |
| September 30, 2022 | 436.10M |
| June 30, 2022 | 459.43M |
| March 31, 2022 | 461.19M |
| December 31, 2021 | 485.28M |
| September 30, 2021 | 503.46M |
| June 30, 2021 | 523.72M |
| Date | Value |
|---|---|
| March 31, 2021 | 543.10M |
| December 31, 2020 | 559.20M |
| September 30, 2020 | 314.24M |
| June 30, 2020 | 329.58M |
| March 31, 2020 | 234.10M |
| December 31, 2019 | 250.42M |
| September 30, 2019 | 151.44M |
| June 30, 2019 | 143.54M |
| March 31, 2019 | 154.33M |
| December 31, 2018 | 152.19M |
| September 30, 2018 | 153.82M |
| June 30, 2018 | 59.29M |
| March 31, 2018 | 65.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
234.10M
Minimum
Mar 2020
678.55M
Maximum
Dec 2022
482.25M
Average
500.83M
Median
Total Assets (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 93.67B |
| Nuvalent Inc | 1.189B |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 116.74M |
| Shareholders Equity (Quarterly) | 381.46M |